Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,870 | 540 | 810 | 800 | 1,070 |
| TOTAL | $1,870 | $540 | $810 | $800 | $1,070 |
| Non-Current Assets | |||||
| PPE Net | N/A | 470 | N/A | N/A | 680 |
| TOTAL | $N/A | $470 | $N/A | $N/A | $680 |
| Total Assets | $1,870 | $1,010 | $810 | $800 | $1,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,920 | 2,010 | 1,070 | 1,650 | 460 |
| Accrued Expenses | 5,160 | 4,530 | 4,400 | 4,880 | 3,550 |
| Other current liabilities | 830 | 1,250 | 1,660 | 2,080 | 2,500 |
| TOTAL | $7,910 | $7,790 | $7,130 | $8,610 | $6,510 |
| Non-Current Liabilities | |||||
| TOTAL | $30 | $40 | $40 | $50 | $50 |
| Total Liabilities | $7,940 | $7,830 | $7,170 | $8,660 | $6,560 |
| Shareholders' Equity | |||||
| Common Shares | 110 | 110 | 110 | 100 | 100 |
| TOTAL | $81,720 | $81,110 | $81,050 | $78,040 | $77,470 |
| Total Liabilities And Equity | $89,660 | $88,940 | $88,220 | $86,700 | $84,030 |